Cargando…

Effect of a patient-support program on once-daily teriparatide adherence and persistence in the Japan Fracture Observational Study (JFOS)

SUMMARY: Japanese patients with osteoporosis prescribed once-daily teriparatide for 24 months could enroll in a patient-support program designed to aid adherence and persistence. Patients enrolled in the program had higher adherence and persistence rates than those who did not enroll, highlighting t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Masayo, Tsujimoto, Mika, Kajimoto, Kenta, Uetake, Hideyuki, Shimoda, Hiroo, Fujiwara, Saeko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer London 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310708/ https://www.ncbi.nlm.nih.gov/pubmed/29978364 http://dx.doi.org/10.1007/s11657-018-0487-8

Ejemplares similares

Adherence and Persistence with Once-Daily Teriparatide in Japan: A Retrospective, Prescription Database, Cohort Study
por: Tanaka, Ikuko, et al.
Publicado: (2013)

How different is the once-weekly teriparatide from the daily one or the same?
por: Takeuchi, Yasuhiro
Publicado: (2019)

Safety and effectiveness of daily teriparatide for osteoporosis in patients with severe stages of chronic kidney disease: post hoc analysis of a postmarketing observational study
por: Nishikawa, Atsushi, et al.
Publicado: (2016)

Safety of daily teriparatide treatment: a post hoc analysis of a Phase III study to investigate the possible association of teriparatide treatment with calcium homeostasis in patients with serum procollagen type I N-terminal propeptide elevation
por: Yamamoto, Takanori, et al.
Publicado: (2015)

Treatment responses with once-weekly teriparatide therapy for osteoporosis
por: Shiraki, M., et al.
Publicado: (2016)

Once-weekly teriparatide improves glucocorticoid-induced osteoporosis in patients with inadequate response to bisphosphonates
por: Seno, Takahiro, et al.
Publicado: (2016)

Nonsurgical Corrective Union of Osteoporotic Vertebral Fracture with Once-Weekly Teriparatide
por: Miyakoshi, Naohisa, et al.
Publicado: (2015)

Impact of patient background factors on the treatment efficacy of once-weekly teriparatide
por: Omura, Fumitoshi
Publicado: (2019)

Teriparatide Induced Delayed Persistent Hypercalcemia
por: Thiruchelvam, Nirosshan, et al.
Publicado: (2014)

The effects of once-weekly teriparatide on hip structure and biomechanical properties assessed by CT
por: Ito, M., et al.
Publicado: (2013)

Utility of radius bone densitometry for the treatment of osteoporosis with once-weekly teriparatide therapy
por: Nakayama, Harumi, et al.
Publicado: (2018)

Treatment for Osteoporosis among Women in Japan: Associations with Patient Characteristics and Patient-Reported Outcomes in the 2008–2011 Japan National Health and Wellness Surveys
por: Sato, Masayo, et al.
Publicado: (2014)

Once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis: reply to T. Kawada
por: Sugimoto, T., et al.
Publicado: (2014)

Effects of treatment interruption due to patient convenience on treatment of once a week teriparatide
por: Katahira, Genichiro, et al.
Publicado: (2020)

Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma
por: O’Byrne, Paul M., et al.
Publicado: (2014)

New simulation model for bone formation markers in osteoporosis patients treated with once-weekly teriparatide
por: Tanaka, Sakae, et al.
Publicado: (2014)

Adherence and Persistence with Once-Daily vs Twice-Daily Direct Oral Anticoagulants Among Patients with Atrial Fibrillation: Real-World Analyses from the Netherlands, Italy and Germany
por: Smits, Elisabeth, et al.
Publicado: (2022)

Bone fractures and feeling at risk for osteoporosis among women in Japan: patient characteristics and outcomes in the National Health and Wellness Survey
por: Sato, Masayo, et al.
Publicado: (2014)

Among once-daily regimens, single tablet regimens (STRs) are associated with better adherence
por: Murri, R, et al.
Publicado: (2012)

Effect of an intensive conservative therapy with daily teriparatide administration and rehabilitation for osteoporotic delayed vertebral collapse and paralysis
por: Wakao, Norimitsu, et al.
Publicado: (2018)

Once-daily dosing of gentamicin.
por: Soper, D E
Publicado: (1998)

Safety and effectiveness of daily teriparatide in a prospective observational study in patients with osteoporosis at high risk of fracture in Japan: final report
por: Nishikawa, Atsushi, et al.
Publicado: (2016)

Association of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients: a retrospective cohort study
por: Hazel-Fernandez, Leslie, et al.
Publicado: (2013)

Adherence to GLP-1 receptor agonist therapy administered by once-daily or once-weekly injection in patients with type 2 diabetes in Germany
por: Qiao, Qing, et al.
Publicado: (2016)

Impact of Once-Daily Versus Twice-Daily Dosing Frequency on Adherence to Chronic Medications among Patients with Venous Thromboembolism
por: Laliberté, François, et al.
Publicado: (2013)

Real-world adherence to, and persistence with, once- and twice-daily oral disease-modifying drugs in patients with multiple sclerosis: a systematic review and meta-analysis
por: Nicholas, Jacqueline A., et al.
Publicado: (2020)

Cost-effectiveness of sequential daily teriparatide/weekly alendronate compared with alendronate monotherapy for older osteoporotic women with prior vertebral fracture in Japan
por: Mori, Takahiro, et al.
Publicado: (2021)

Renal Phosphate Reabsorption is Correlated with the Increase in Lumbar Bone Mineral Density in Patients Receiving Once-Weekly Teriparatide
por: Takeuchi, Yasuhiro, et al.
Publicado: (2015)

Study of twice-weekly injections of Teriparatide by comparing efficacy with once-weekly injections in osteoporosis patients: the TWICE study
por: Sugimoto, T., et al.
Publicado: (2019)

Association between teriparatide treatment persistence and adherence, and fracture incidence in Taiwan: analysis using the National Health Insurance Research Database
por: Chan, D.-C., et al.
Publicado: (2016)

Modelling the effect of beliefs about asthma medication and treatment intrusiveness on adherence and preference for once-daily vs. twice-daily medication
por: Chapman, Sarah, et al.
Publicado: (2017)

Treatment of spontaneous osteonecrosis of the knee by daily teriparatide: A report of 3 cases
por: Horikawa, Akira, et al.
Publicado: (2020)

ONCE DAILY RISPERIDONE IN TREATMENT OF SCHIZOPHRENIA
por: Agarwal, Vivek, et al.
Publicado: (2001)

A multicenter, randomized, rater-blinded, parallel-group, phase 3 study to compare the efficacy, safety, and immunogenicity of biosimilar RGB-10 and reference once-daily teriparatide in patients with osteoporosis
por: Hagino, H., et al.
Publicado: (2019)

SAT-505 A Rare Case of Teriparatide Induced Persistent Hypercalcemia
por: Sistla, Divya, et al.
Publicado: (2019)

An observational study of once-daily modified-release methylphenidate in ADHD: quality of life, satisfaction with treatment and adherence
por: Rothenberger, Aribert, et al.
Publicado: (2011)

Once-weekly teriparatide increases bone mineral density in the distal 1/10 radius, but not in the distal 1/3 radius
por: Urushibara, Nobuo, et al.
Publicado: (2014)

Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis
por: Sugimoto, T., et al.
Publicado: (2013)

Safety and efficacy in actual clinical practice of once-weekly subcutaneous teriparatide for osteoporosis patients with a high fracture risk
por: Ifuku, Emiko, et al.
Publicado: (2019)

Efficacy of once-weekly and twice-weekly injections of teriparatide by patient characteristics: A post hoc analysis of the TWICE study
por: Sugimoto, Toshitsugu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ojbmflgah145h262siqlfhragr